Verition Fund Management
HUMAW icon

Verition Fund Management’s Humacyte Inc Warrant HUMAW Stock Holding History

Verition Fund Management’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,000
Closed -$18K – 2401
2022
Q3 		$18K Hold
15,000
– – ﹤0.01% 2797
2022
Q2 		$48K Hold
15,000
– – ﹤0.01% 2152
2022
Q1 		$29K Hold
15,000
– – ﹤0.01% 2557
2021
Q4 		$34K Hold
15,000
– – ﹤0.01% 2453
2021
Q3 		$44K Hold
15,000
– – ﹤0.01% 1786
2021
Q2 		$42K Hold
15,000
– – ﹤0.01% 1814
2021
Q1 		$45K Buy
+15,000
New +$35.5K ﹤0.01% 1481

Other funds holding HUMAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Verition Fund Management's HUMAW Position: Q4 2022 in Review

Verition Fund Management sold out of Humacyte Inc Warrant (HUMAW) in Q4 2022, closing a stake of 15,000 shares — an estimated $18K sold.

Verition Fund Management first reported a position in HUMAW in Q1 2021 and held it in 7 quarters. The position peaked at $48K in Q2 2022. 10 funds tracked by Wall St. Rank hold HUMAW as of Q4 2022.

  • Verition Fund Management reported no remaining Humacyte Inc Warrant position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 15,000 Humacyte Inc Warrant shares in Q4 2022, an estimated $18K.
  • Verition Fund Management first reported a position in Humacyte Inc Warrant in Q1 2021 and held it in 7 quarters.
  • Verition Fund Management's Humacyte Inc Warrant position peaked at $48K in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.